Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C, Pozniak A, Boffito M, Waters L, Burger D, Back DJ, Khoo S. Marzolini C, et al. Among authors: gibbons s. Clin Pharmacol Ther. 2022 Dec;112(6):1191-1200. doi: 10.1002/cpt.2646. Epub 2022 Jun 7. Clin Pharmacol Ther. 2022. PMID: 35567754 Free PMC article. Review.
Therapeutic drug monitoring.
Back D, Khoo S, Gibbons S. Back D, et al. Among authors: gibbons s. J Int Assoc Physicians AIDS Care (Chic). 2002 Summer;1(3):84-5. doi: 10.1177/154510970200100301. J Int Assoc Physicians AIDS Care (Chic). 2002. PMID: 12942679 No abstract available.
Pharmacokinetic drug interactions with nevirapine.
Back D, Gibbons S, Khoo S. Back D, et al. Among authors: gibbons s. J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S8-14. doi: 10.1097/00126334-200309011-00003. J Acquir Immune Defic Syndr. 2003. PMID: 14562853
Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)--a randomized controlled trial of therapeutic drug monitoring and adherence support.
Khoo SH, Lloyd J, Dalton M, Bonington A, Hart E, Gibbons S, Flegg P, Sweeney J, Wilkins EG, Back DJ. Khoo SH, et al. Among authors: gibbons s. J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):461-7. doi: 10.1097/01.qai.0000218345.65434.21. J Acquir Immune Defic Syndr. 2006. PMID: 16652054 Clinical Trial.
HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.
Hartkoorn RC, Kwan WS, Shallcross V, Chaikan A, Liptrott N, Egan D, Sora ES, James CE, Gibbons S, Bray PG, Back DJ, Khoo SH, Owen A. Hartkoorn RC, et al. Among authors: gibbons s. Pharmacogenet Genomics. 2010 Feb;20(2):112-20. doi: 10.1097/FPC.0b013e328335b02d. Pharmacogenet Genomics. 2010. PMID: 20051929 Free PMC article.
617 results